Navigation Links
What parasites eat is the key to better drug design
Date:8/5/2011

A team led by Professor Malcolm McConville from the Bio21 Institute, University of Melbourne developed a new analytical method which can be used for many infectious parasites and bacteria. The technique has revealed which metabolic pathways are essential for the parasite's survival, down to the particular atoms it uses as a food source.

"This a very significant breakthrough in this field because the more we know about these dangerous pathogens and how they live, the better we can fight them with new, effective drugs," said Professor McConville.

"Current anti-parasitic drugs have enormous side effects as they don't target specific pathogen metabolic pathways. We now have a greater understanding of Leishmania and can develop specific drugs with minimal side effects."

The team studied the parasite's metabolism by labelling carbon atoms in its food source (the sugar glucose) and using cutting edge equipment including nuclear magnetic resonance (NMR) to follow how the atoms were used in the parasite's metabolism. The results reveal which of the metabolic pathways are essential to Leishmania's survival, and therefore good drug targets to block and kill the parasite.

The parasite Leishmania was used to develop the technique as its complex life cycle and ability to infect many animals makes treatment very difficult and limits the effectiveness of a vaccine .

Leishmania causes a range of infections in humans, from skin conditions to organ infection which can be fatal. The parasite lives within tiny sandflies which bite an animal or human to get the blood they require to produce eggs, thereby passing on the Leishmania parasite.

The new study is published in the current issue of the international Journal of Biological Chemistry.


'/>"/>

Contact: Sally Sherwen
sherwens@unimelb.edu.au
038-344-8151
University of Melbourne
Source:Eurekalert

Page: 1

Related biology news :

1. Scripps Florida scientists awarded $1.5M to fight major water and food parasites
2. Locking parasites in host cell could be new way to fight malaria
3. Immune genes adapt to parasites
4. Study finds role for parasites in evolution of sex
5. Discovery to aid in future treatments of third-world parasites
6. Parasites ready to jump
7. Penn researchers identify immune cells that fight parasites may promote allergies and asthma
8. Immune evasion common in many viruses, bacteria and parasites is uncommon in M. tuberculosis
9. Discovery offers hope of saving sub-Saharan crops from devastating parasites
10. MIT researchers study the danger of toxoplasma parasites
11. Comparison of genomes of plant parasites provides solid clues for response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
(Date:2/8/2017)... YORK , Feb. 8, 2017 About ... individual,s voice to match it against a stored ... such as pitch, cadence, and tone are compared ... require minimal hardware installation, as most PCs already ... for different transactions. Voice recognition biometrics are most ...
(Date:2/8/2017)... Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion in ... a compound annual growth rate (CAGR) of 24.0% through 2021. ... for synthetic biology. - Analyses of global market trends, with ... annual growth rates (CAGRs) through 2021. - Coverage of core ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... ... March 23, 2017 , ... AxioMed president, Jake Lubinski, describes ... characteristics when deformed, which is identical to how the human discs work to ... and return to its natural state along a hysteresis curve, exactly like a ...
(Date:3/23/2017)... -- GlobeImmune, Inc. today announced it has entered into a ... of its common stock to NantCell, Inc., a member ... sale of its common stock, NantCell has agreed to ... 200,000 shares, an estimated $2.0 million in value, of ... to enter into this strategic agreement with NantCell," said ...
(Date:3/23/2017)... York , March 23, 2017 According ... plasma products and derivatives market is fragmented due to the presence of ... such as Proliant, Thermo Fisher , and Sigma-Aldrich, compete with ... these three companies, collectively, held more than 76% of this market ... As ...
(Date:3/22/2017)... ... March 22, 2017 , ... Researchers face a ... lab samples to full-size tissues, bones, even whole organs to implant in people ... delivers blood deep into the developing tissue. , Current bioengineering techniques, including ...
Breaking Biology Technology: